Introduction

Urea, one of the most ubiquitous organic compounds in nature, is the nitrogen source for many bacteria, a buffer that enables the survival of particular pathogens in acidic stomachs, and the final product of amino acid metabolism in the body of human and animals1,2,3. Whereas rays and sharks use urea to sustain isosmotic activity against sea water, mammals normally concentrate urea up to hundreds of fold in the kidney to establish the osmotic gradient necessary for water reabsorption and urine concentration4,5,6. Moreover, urea nitrogen recycling plays key roles in the protein balance of mammals during hibernation7. Because urea has a stronger dipole moment than water, the free diffusion of urea across the plasma membrane is very slow. To facilitate urea transport in body, many organisms encode urea transporter (UT) genes, which are expressed as transmembrane proteins that play major roles in mediating the rapid transmembrane permeation of urea. The urea permeation rate of UTs is generally 104 – 106 urea molecules per second, which is 10 to 100 times higher than the rate of free diffusion. UTs play essential roles in balancing urea generation and excretion of normal physiological processing8.

Two subfamilies of UT have been found in mammals, UT-A and UT-B, which are encoded by the genes Slc14a2 and Slc14a1, respectively. The Slc14a2 gene of Homo sapiens produces four UT-A members, named hUT-A1 to -A3 and hUT-A6, by different promoters and alternative mRNA splicing (Fig. 1a and Supplementary Fig. 1a)9,10. UTs are expressed in various tissues throughout the human body. Four UT types, hUT-A1-A3 and hUT-B, play important roles in the urea recycling in the kidney, and hUT-A6 is expressed in human colon tissue. In addition, rat UT-A4 (rUT-A4) is found only in the renal medulla, while mouse UT-A5 (mUT-A5) is expressed only in the testis11 (Fig. 1a). UT-A1 is the largest member in the UT family, consisting of 920 amino acids. UT-A2 consists of 396 amino acids that are the same as amino acids 524–920 of UT-A1. UT-A3 consists of amino acids 1–451 of UT-A1 (Supplementary Fig. 1a). UT-B shares 61.6% sequence similarity with UT-A2. In the kidney, UT-A1 and UT-A3 are expressed in the principal cells of the inner medullary collecting duct (IMCD), UT-A2 is expressed in the thin descending limb (TDL) of the loop of Henle, and UT-B is expressed in the renal descending vasa recta (DVR) (Fig. 1b). These four types of UT are responsible for the rapid urea recycling in the kidney12.

Fig. 1: Expression and functional characterization of the urea transporters.
figure 1

a The dendrogram clustering representation of the evolutionary relationship of UTs from different species, including human, bovine, mouse, rat, zebrafish and Desulfovibrio vulgaris (dv_UT). Five UT members are expressed in human, containing UT-B and four UT-As. The squares and the circles represent UTs encoded by gene Slc14a1 and Slc14a2, respectively. The UTs whose structure were determined in our paper are highlighted with red color. dv, Desulfovibrio vulgaris. b Tissue distribution of UT expressed in the human kidneys. UT-A1 and UT-A3 are expressed in the principal cells of the inner medullary collecting duct (IMCD), UT-A2 is expressed in the thin descending limb (TDL) of the loop of Henle, and UT-B is expressed in the renal descending vasa recta (DVR). c The membrane expression levels of the human UT-A1-A3, UT-B and zf-UT, which were overexpressed in SF9 cells using a Bac-to-Bac baculovirus expression system. Data are represented as mean ± SEM from 3 independent experiments (n = 3). d The size-exclusion chromatography elution profiles of the purified hUT-A2 on Superose 6 Increase 10/300 column. The peak of hUT-A2 was approximately 14.5 ml. e Representative SDS-PAGE results of the purified hUT-A2 (n = 2). After cross-linking with glutaraldehyde, the hUT-A2 showed at a size corresponding to trimer form displayed on the SDS-PAGE. f Schematic diagram of the 14C-labeled urea transportation assay. Each cell well was incubated with 300 μl of DMEM supplemented with 10 mmol/L urea and 1 μCi of 14C-urea for 30 min. After incubation, the cells were washed with cold 1xPBS. Then, the cells were lysed and transferred into 5 ml of scintillation fluid in a scintillation vial for measured by using a scintillation counter. The detailed experimental procedures are shown in the Methods section. g Urea permeability shown by the detection of remaining 14C-labeled urea. Columns of cells treated with vehicle or 100 μM inhibitor 25a are colored gray or orange respectively. Data are represented as mean ± SEM from 3 independent experiments (n = 3). ***P < 0.001, statistical differences were determined by the two-sided unpaired Student’s t-test (compared with vehicle).

Functional abnormalities of UT are known to lead to abnormal distribution of urea in the body, causing urine concentrating defects, as well as affecting the cardiovascular and nervous systems, which may increase the cardiovascular burden and cause cognitive impairments13,14,15. The aberrant urea metabolism mediated by increased levels of UT could be one of the key elements of the neuropathogenesis of Huntington’s disease16. Blocking UTs with inhibitors can inhibit the concentration of urine in the kidney and exert osmotic diuretic effect without affecting electrolyte excretion10, suggesting therapeutic potential as diuretics, which can be used for the long-term treatment of heart failure, edema, hypertension and so on17. However, the use of existing UT inhibitors as diuretics is hampered by their low affinity and poor selectivity, which can cause numerous side effects. Recently, the structures of a bacterial homolog UT and of bovine UT-B have been solved. Parallel to our work, the apo structures of human UT-A3 and UT-B and of UT-B bound with the selective inhibitor UTBinh-14, have been reported18. However, urea transport by UTs has not been directly observed, and the structural mechanisms that underlie urea transport and could enable the design of inhibitors targeting UT-A remain elusive. Notably, selective inhibitors targeting UT-A1-A3 are desired for diuretic usage instead of nonselective inhibitors or UT-B-selective inhibitors because UT-B is widely distributed throughout the body and UT-B inhibitors may therefore have side effects in nonrenal tissues10.

In this study, we present high-resolution structures of four apo UTs, human hUT-A2, hUT-A3, and hUT-B and zebrafish UT, as well as seven structures of these UTs in complex with urea, the competitive inhibitors 25a and ATB3, the uncompetitive inhibitor CF11 and the noncompetitive inhibitor HQA2. Combined with activity measurement, computational molecular dynamics (MD) simulation and mutational analysis, these structures provide important mechanistic insights into urea transport by UTs and selective competitive, uncompetitive or noncompetitive inhibitor designs targeting hUT-As.

Results

Expression and functional characterization of human UT

To facilitate the structural determination of UTs, we screened the plasma membrane expression levels of UT proteins. Flag tags were added to the N-termini of zebrafish UT (zf-UT) and human UT-A1, A2, A3, and UT-B sequences, and the mCherry protein was fused by the TEV cleavage site and GSA linker at the C-termini. zf-UT had the highest plasma membrane expression, followed by hUT-A2, hUT-A3 and hUT-B, whereas hUT-A1 showed no detectable expression in the insect cell membrane (Fig. 1c). Further examination of UT proteins by size exclusion column chromatography showed that the elution volumes of four highly expressed UT proteins (approximately 14.5 ml in Sepharose 6) were significantly earlier than those of the expected monomer proteins (approximately 17 ml), suggesting that these four UT proteins existed in the multimer forms (Fig. 1d and Supplementary Fig. 1b–d). Cross-linking with glutaraldehyde followed by gel electrophoresis suggested that the four highly expressed UT proteins all existed as trimers (Fig. 1e). These observations recalled previous reports of the trimer formation of Desulfovibrio vulgaris UT (dv_UT) and bovine UT-B1,19. Importantly, urea permeability, measured using the urease assay and 14C-labeled urea transport assay, was significantly higher in HEK293 cells transfected with zf-UT, hUT-A2, hUT-A3, and hUT-B than in HEK293 cells transfected with the control pcDNA3.1 plasmid (Fig. 1f, g and Supplementary Fig. 1e, f). Moreover, the urea permeability of hUT-A2, hUT-A3, hUT-B, and zf-UT was blocked by the small-molecule inhibitor 25a (Fig. 1f, g).

Overall cryo-EM structures of the UT trimers

We then determined nine structures of hUT-A2 and zf-UT in the resting state and bound to endogenous urea, the competitive inhibitor 25a or ATB3, the uncompetitive inhibitor CF11, or the noncompetitive inhibitor HQA2 via single-particle cryo-electron microscopy at resolutions ranging from 2.6 to 3.3 Å (Fig. 2a, d and Supplementary Figs. 25 and Supplementary Tables 1 and 2). The cryo-EM structures of hUT-A3 and hUT-B in the absence of urea were also solved at resolutions of 2.3 Å and 2.4 Å (Fig. 2b, c and Supplementary Fig. 4 and Supplementary Table 2). The cryo-EM densities allowed the assignment of most residues of the UT proteins, including residues 51 to 381 of hUT-A2, residues 96 to 440 of hUT-A3, residues 34 to 383 of hUT-B and residues 31 to 380 of zf-UT (Supplementary Table 3). The density of urea and inhibitors could also be assigned in the hUT-A2 and zf-UT structures in either intracellular or extracellular regions of the transport channels (Fig. 2a, d).

Fig. 2: Cryo-EM structures of hUT-A2, hUT-A3, hUT-B and zf-UT.
figure 2

a–d Overall cryo-EM densities and structures of hUT-A2 (a), hUT-A3 (b), hUT-B (c) and zf-UT (d) homotrimer. The cryo-EM densities of different UTs are displayed on the phospholipid bilayer cell membrane with the represent cartoon models shown below. Molecules bound to the extracellular and intracellular sides of different UTs, along with their corresponding EM densities, are indicated in dashed circles at the top and bottom layers, respectively. Created in BioRender. Huang, S. (2024) https://BioRender.com/h99o001.

Consistent with the electrophoresis results, zf-UT, hUT-A2, hUT-A3 and hUT-B all existed as homologous trimers in the solved cryo-EM structures (Fig. 2 and Supplementary Fig. 6a–d). In all these UT structures, each UT unit consists of 10 complete transmembrane helices and 2 semi-transmembrane helices distributed symmetrically along the axis of the urea transport channel, which were named 1a–5a, 1b–5b, and Pa, and Pb, respectively (Supplementary Fig. 6e). The two symmetric halves of each UT subunit are named the a-half and b-half, respectively, and are connected by a long extracellular loop (LECL) (Supplementary Fig. 6e). The urea transport channels of all UTs are enclosed by helices from both halves, including helices 3a, 3b, 5a, 5b, Pa, and Pb (Fig. 3a and Supplementary Fig. 6a–e)1,19. Both the N-terminus and C-terminus of each UT subunit face the intracellular side. A portion of the C-terminus of UT folds into a helical-like structure and is named the C1 helix. Between the C1 helix and helix 5b is the long intracellular loop (LICL), which is also located on the cytoplasmic side (Supplementary Fig. 6e).

Fig. 3: Visualize the urea transportation across the channel of hUT-A2.
figure 3

a The urea transport channel of hUT-A2 is shown as blue dots with the surrounding helices displayed as cylindrites. The urea transport channel of hUT-A2 is a continuous cavity with a length of approximately 21 Å which enclosed by helices from both halves, including helices 3a, 3b, 5a, 5b, Pa, and Pb. b The EM density in the urea binding pocket of hUT-A2 at the 4.0 σ contour level are shown as red mesh on both the extracellular and cytoplasmic sides of the urea transport channel. c The extracellular urea binding pocket (EUBP) and the cytoplasmic urea binding pocket (CUBP) of hUT-A2. d, e. The key residues interacting with urea in EUBP (d) and CUBP (e) are shown as sticks while the urea and water molecules are displayed as stick-balls and red balls, respectively. The H-bond are shown as red dash line. f Structurally equivalent residues in the EUBP (left) and CUBP (right) of hUT-A2 compared with other hUTs and zf-UT. The secondary structure of the indicated residues is shown at the top. The conserved QPb-T5b-T5a-QPa motif of urea transport channel in different UTs is shown in blue backgrounds. g, h Urea permeability shown by the detection of remaining 14C-labeled urea in cell transfected with hUT-A2 (g) and zf-UT (h). Cells transfected with wild type and mutant UT plasmids are shown as gray and green columns respectively, while cells transfected with pcDNA3.1 blank plasmids for control are shown as blank column. Data are represented as mean ± SEM from 3 independent experiments (n = 3). ***P < 0.001, statistical differences were determined by the two-sided unpaired Student’s t-test (compared with wild type).

Importantly, most structural differences between different UTs are located in the N-terminus, C-terminus, LECL and long intracellular loop (LICL). Compared with the structure of hUT-A2, the N-terminus of hUT-A3 has an extra α helix, named the N1 helix. The C1 helix of hUT-A3 is one helical turn shorter than the C1 helix of hUT-A2 and is rotated outward by approximately 8° (Supplementary Fig. 6f). Compared with hUT-A2, the N-terminus of hUT-B has two more helical structures, which are named N1 and N2. The C1 helix of UT-B is rotated outward by approximately 11°, and the intracellular ends of helix 4a, LECL and LICL are shifted inward compared with the corresponding positions in UT-A2 (Supplementary Fig. 6g). The N-terminus of zf-UT is similar to the N-terminus of hUT-B, with two helices, N1 and the N2. Compared to hUT-A2, the C1 helix of zf-UT is rotated outward by approximately 6°, and the LECL and LICL are shifted inward (Supplementary Fig. 6h).

Capture of urea in the urea transport channel

In the hUT-A2 structure, the urea transport channel connecting the extracellular section to the intracellular region is composed of helices 3a, 3b, 5a, 5b, Pa, and Pb. The channel is a continuous cavity that is wide at both ends and narrow in the middle, with a length of approximately 21 Å (Fig. 3a). Compared with the apo-hUT-A2 structure, the additional EM density in this potential urea transport channel at the 4.0 σ contour level enabled us to model the urea molecule and its coupled water on both the extracellular and cytoplasmic sides (Fig. 3b and Supplementary Fig. 7a, b). The modeled urea molecules were further supported by molecular dynamics simulation (Supplementary Fig. 7c). There are two urea binding pockets in the channel: one in the extracellular urea binding pocket (EUBP) and the other in the cytoplasmic urea binding pocket (CUBP), separated by approximately 10 Å (Fig. 3c–e). In total, 7 residues compose the EUBP, and the largely hydrophobic environment is decorated with many polar groups. In the EUBP, two nitrogen atoms of the upper urea form a salt bridge with the main chain carbonyl oxygens of Q231Pb and V232Pb, a hydrogen bond with the side chain of T3385b and a water-mediated hydrogen bond with the side chain of Q231Pb (Fig. 3d). In addition to polar interactions, urea molecules form a cation-π interaction with the benzene ring of F2873b and van der Waals interactions with L1313a, F1795a, and C3375b (Fig. 3d).

The CUBP consists of 5 hydrophobic residues and 2 polar residues (Fig. 3e). Notably, the lower urea molecule in the CUBP form symmetric polar interactions and hydrophobic packing compared with the upper urea molecule in the EUBP, including interactions with the main chain carbonyl groups of Q67Pa and V68Pa and the side chain of T1765a, as well as cation-π interactions with F70Pa and Y1233a (Fig. 3e). The motif Q67PaV68PaY1233aT1765a in the CUBP and the motif Q231PbV/I232PbF/Y2873bT3385b in the EUBP are conserved among UT-A2, UT-A3, UT-B and zf-UT and thus could be a “urea recognition motif (URM)” in UTs (Fig. 3f). In addition, the lower urea molecule in the CUBP forms contacts with F1755a and F3415b (Fig. 3e). Consistent with these observations, alanine mutations of the residues in the URM of either the CUBP or the EUBP, such as Y1233a and T1765a in the CUBP or Q231Pb F/Y2873b and T3385b in the EUBP significantly decreased urea transport by these UTs (Fig. 3g, h and Supplementary Fig. 7d–g).

Potential urea permeation mechanism of the human urea transporter hUT-A2

Compared with that of apo-hUT-A2, the pore size of the urea transport channel of urea-bound hUT-A2 is significantly smaller, and the mean radius is decreased by approximately 0.3 Å (Fig. 4a and Supplementary Fig. 7h). The shrinkage of the channel radius is mainly due to the inward movements of residues such as F70Pa, Y1233a, L1273a, L1313a, F1795a and F2873b (Supplementary Fig. 7i). We speculated that the hydrogen bonding and hydrophobic interactions of urea in the urea transport channel are the driving forces for channel cavity shrinkage and the resulting smaller radius (Fig. 4b). The UT transport channels are divided into three parts, So, Sm, and Si, from the extracellular to the cytoplasmic side. In the So region, the urea molecule forms a salt bridge with the main chain oxygen atoms of Q231Pb and V232Pb and a hydrogen bond with the hydroxyl group of T3385b (Fig. 4b). The hydrophobic side chains of L1313a and F2873b provide steric hindrance for the orientation of the urea molecule. These interactions induce the inward movements of several residues inside the transport channel, such as L1273a, L1313a, and F1795a, as well as F2873b on the other side (Supplementary Fig. 7i).

Fig. 4: Urea permeation mechanism of the human urea transporter hUT-A2.
figure 4

a The urea transport channel of hUT-A2 is highlighted by blue dotted line with the inner urea molecules displayed as stick-balls. b The hydrogen bonding and hydrophobic interactions of urea in the urea transport channel of hUT-A2. The black dashed lines are used to separate So, Sm, and Si regions of the channel. The H-bond are shown as red dashed line and the cation-π interaction are shown as purple dashed lines. c Free energy surface (FES) of urea within the hUT-A2 channel. The simulation reveals three distinct low-energy states, which are characterized by prolonged urea residence times across defined regions within the channel and corresponds to the So, Sm, and Si regions respectively. d Simplified one-dimensional energy landscape highlighting the So, Sm, and Si states of urea within the hUT-A2 channel. e Metadynamics analysis depicts urea dynamically transitioning between three states-So, Sm, and Si-within the hUT-A2 channel, with distribution probabilities of 37%, 19%, and 34%, respectively. fh Metadynamics simulations elucidate the passage of urea through the Sm region. This process involves a rotation of approximately 40°in the side chains of T1765a and T3385b, facilitating the rearrangement of T1765a–T3385b side chains (f). Notably, hydrogen bond formations between urea and specific residues, including T3385b and T1765a, are depicted (g). The rotation of side chains of T338/T176 and structural rearrangement of L127/L291 form a hydrophobic cavity in the Sm region, guiding urea transportation across the channel (h). The H-bond are shown as red dashed line. The blue arrows indicate the direction of movement of the urea molecule. i Urea permeability shown by the detection of remaining 14C-labeled urea in cell transfected with different hUT-A2. plasmids are shown as gray and green columns respectively, while cells transfected with pcDNA3.1 blank plasmids for control are shown as blank column. Data are represented as mean ± SEM from 3 independent experiments (n = 3). **P < 0.01, ***P < 0.001, statistical differences were determined by the two-sided unpaired Student’s t-test (compared with wild type). j Schematic diagram of urea permeation mechanism of hUT-A2.

The urea molecule in the Si region shows a similar symmetric bonding pattern. The Sm region of the UT transport channel is a relatively narrow cavity consisting of three residue pairs, namely, T1765a–T3385b, L1273a–L2913b, and F1793a–F3413b (Fig. 4b). The pore radius of this central core of the Sm region is significantly smaller than that of the So and Si regions (Supplementary Fig. 7h). Because our current cryo-EM data of urea-hUT-A2 could not capture clear EM density inside the Sm region, we performed MD simulation to explore the process of urea molecule passing through the Sm region (Supplementary Fig. 7j). The simulation captured three low-energy states with longer residence times of urea across the channel, located in the three defined regions, So, Sm, and Si, with distribution probabilities of time of 37%, 19% and 34%, respectively (Fig. 4c–e). According to kinetic simulation and cluster analysis, the side chains of T1765a and T3385b rotated by approximately 40° followed by the rearrangement of the side chains of T1765a–T3385b and F1793a–F3413b to allow the urea molecule to pass through the Sm region. In the Sm region, the oxygen atom of urea formed hydrogen bonds with the hydroxyl group of the T1765a-T3385b, while the nitrogen atom formed hydrogen bonds with the main chain carbonyl group of V68Pa-V232Pb (Fig. 4f, g). Moreover, the polar urea molecules also interacted with the hydrophobic side chains of T3385b/T1765a, V232Pb/V68Pa and L1273a/L2913b through van der Waals forces in the Sm region (Fig. 4g, h). The urea molecules were sterically restricted by the side chains of amino acids L1273a–L2913b and F1793a–F3413b in the Sm region (Fig. 4h). Therefore, urea molecules shuttle through the transport channel in the form of a “monolith”, supporting a previous hypothesis1,19. We speculated that the urea molecule rotated via H-bond formation with the Q231Pb–T3385b–T1765a–Q67Pa motif during transportation (Supplementary Movie). Consistent with these simulation results and our hypothesis, the mutations Q67A, T176A, Q231A and T338A etc. of hUT-A2 significantly impaired urea permeation efficiency (Figs. 3g, 4i and Supplementary Fig. 7k, l).

We therefore hypothesized that the transport of urea across hUT-A2 occurs in three steps. In the first step, free urea molecules in solution are captured by the flexible side chain of Q231Pb in the extracellular region. The urea molecules are then brought into the So region of the transport channel by the rotation of the side chain of Q231Pb and coordinated by water molecules. At this stage, the two basic nitrogen atoms of the urea molecule form a salt bridge with the negatively charged poles of the Pa helix backbone (carbonyl oxygen atoms of the Q231Pb and V232Pb main chains). The hydrophobic nature of L1313a–F2873b facilitates a defined orientation of the urea molecule on the horizontal plane. In the second step, the flexibility of the side chains of L1313a and F2873b and hydrogen bond transfer mediated by the side chain of T3385b pull the urea molecules into the Sm region. In particular, rearrangement of the configurations of the residue pairs L1273a–L2913b and F1793a–F3413b may allow the entry of urea molecules. In the third step, the movement of the T1765a side chain may transfer the urea molecules from the Sm region to the Si region, forming an interaction pattern that is symmetric to the interaction pattern of urea in the So region (Fig. 4j). The urea may then move downward to form a hydrogen bond with the side chain of Q67Pa. Finally, the urea bound to the Si region is released into the cytoplasm, thus completing the transport of urea from the extracellular to the intracellular space. We speculated that the formation and transfer of hydrogen bonds between urea and the Q231Pb–T3385b–T1765a–Q67Pa motif play important roles throughout the whole process of urea transport (Fig. 4j). Because the distribution of amino acids in the So and Si regions of the channels is relatively symmetrical, we speculated that urea molecules can be transported from the intracellular end to the extracellular end in a similar manner (Fig. 3f).

Observation of urea transport by zf-UT

The trimer structure of urea-bound zf-UT was solved at an overall resolution of 3.0 Å. Compared with the apo-zf-UT structure, obvious and continuous EM densities enabled easy assignment of urea on both the intracellular and extracellular sides of the zf-UT channel (Figs. 2d, 5a, b and Supplementary Fig. 8a–c). According to the EM density distribution, the urea transport channel contains a vertical tubular cavity composed of 3a, 3b, 5a, 5b, Pa, and Pb helices and then extends into the intracellular section composed of the intracellular ends of helices 3a–5a and ICL2b (Fig. 5c). Due to the continuous EM density, MD simulations were performed to model urea at specific positions of the urea transport channel (Fig. 5d–f).

Fig. 5: Structural analysis and comparison of urea transport in zf-UT and hUTs.
figure 5

a, b Overall view of the urea density in zf-UT trimer. Two portions of obvious and continuous cryo-EM densities corresponding to urea in zf-UT are located at both the intracellular and extracellular sides of the channel (a), which facilitated the unambiguous assignment of urea molecules (b). c Comparison of the transportation channel of zf-UT (blue) and hUT-A2 (green). According to the EM density distribution, the urea transportation channel of zf-UT contained a vertical tubular cavity composed by 3a, 3b, 5a, 5b, Pa, and Pb helices, and then extends into the intracellular section composed by intracellular ends of helices 3a–5a and ICL2b. d Free energy surface (FES) of urea across the zf-UT channel, revealing six low-energy states-So’, So, Sm, Si, Si’, and Si”-associated with extended urea residence times across six distinct regions within the channel. e Simplified one-dimensional energy landscape illustrating the So’, So, Sm, Si, Si’, and Si” states of urea within the zf-UT channel. f The location of the urea molecules are modeled into six regions shown as So’, So, Sm, Si, Si’, and Si” in the zf-UT channel surrounding with presentation of key interacting residues. The urea transport channel of zf-UT is depicted by white dotted line with the inner urea molecules displayed as stick-balls. The conserved QPb–T5b–T5a–QPa motif is shown as green dots. g, h The interactions between urea and the key residues in the zf-UT urea transport channel (shown as blue dots) in the extracellular side (g) and the intracellular side (h) of the channel. The H-bonds are shown as red dashed line. i Barcode comparisons of the residues involving in the urea channel of zf-UT between different UTs. The residues predicted to involve with common interactions with urea molecules are displayed as black circles, including residues of the QPb–T5b–T5a–QPa motif filled with green, while the residues predicted to form distinct interactions are shown as black circles filled with gray. The letters inside the circles represent different amino acids present in the corresponding positions.

Compared with the cryo-EM structure of urea-hUT-A2, the structure of urea-zf-UT has additional EM density connected to the “So” region on the extracellular side, which is named the “So’” region, a cavity created by the side chains of F1353a, L2843b, and P335ECL2b (Fig. 5f and Supplementary Fig. 8b–e). Our MD simulation indicated that F1353a and L2843b form transient interactions with urea during urea transport (Fig. 5f–h). The conservation of F1353a and L2843b among UTs of different species suggested that the channel governed by these two residues is a common path for urea transport (Fig. 5i). On the intracellular side, the EM density of zf-UT-urea enabled the identification of two other urea binding sites, which were named Si’ and Si”, connecting to the Si region via an “L” configuration (Fig. 5b, f, h and Supplementary Fig. 8c). Whereas urea in the Si’ region contacts F3003b and L363ICL2b, urea in the Si” region interacts with Y1213a and S1604a (Fig. 5h and Supplementary Fig. 8c). We noticed that key residues in the urea transport channel, such as Y2873b, L1203a, and Y1213a of zf-UT, were replaced by F, F, and H, respectively (Fig. 5i). These amino acid differences may contribute to the stronger and longer EM density of urea observed in the zf-UT-urea compared with that in the hUT-A2-urea complex structure.

In the So and Si regions of the channel, urea showed similar interaction modes to those in the urea-hUT-A2- structure, including the polar network constituted by the Q231Pb–T3385b–T1765a–Q67Pa motif and hydrophobic interactions involving L1313a, F2873b, F70Pa, and Y1233a, which are distributed along the channel from the extracellular side to the intracellular side (Fig. 5i). These results indicate that a common mechanism and conserved motifs underlie urea transport in UTs from different species.

Competitive inhibition of UT-A2 by 25a

25a is a synthetic competitive inhibitor of UT with potency in the micromolar range (IC50 = 0.58 ± 0.01 μM toward hUT-A2) (Fig. 6a and Supplementary Fig. 9a, Supplementary Table 4). We solved the cryo-EM structure of hUT-A2 with 25a to understand the structural basis of its inhibition and to facilitate more potent and selective UT inhibitor design. Unambiguous EM density corresponding to 25a could be easily assigned on both the extracellular and intracellular sides (Figs. 2a, 6b and Supplementary Fig. 9b). The furan group of 25a, which mimics the urea molecule, inserts deeply into the channel center and occupies the pocket region of the EUBP and CUBP (Fig. 6c–f and Supplementary Fig. 9c–f, Supplementary Table 5). On the extracellular side, the methyl ketone group and amide group on the two sides of furan form hydrogen bonds with the side chains of T338 and Q231 (Fig. 6c, e). In addition to polar interactions, the furan group of 25a undergoes hydrophobic packing with residues in the EUBP, such as L1313a, F1795a, V232Pb, F2873b, and C3373b. On the cytoplasmic side, the furan ring of 25a forms similar interactions in a symmetric manner (Fig. 6c, e).

Fig. 6: The mechanism of inhibition of hUT-A2 by 25a.
figure 6

a The concentration dependent blockade of urea transport of hUT-A2 by 25a using urease assay. Data are shown as mean ± SEM of three independent experiments (n = 3). b The cryo-EM density (orange) of 25a in hUT-A2 homotrimer from top view or side view. The surfaces of three hUT-A2 monomer are represented by orange, green and blue, respectively. c, d The interactions between hUT-A2 and 25a in extracellular blocker binding pocket (EBBP) (c) or cytoplasmic blocker binding pocket (CBBP) (d). The hUT-A2 are represented in blue cartoon and the key amino acids are represented by blue sticks. The 25a was represented by orange stick-ball. e, f The cutaway view of binding pockets of 25a in extracellular side (e) or cytoplasmic side (f). In the extracellular side, the 25a occupied two subpockets, the EBBP1 (extracellular blocker binding pocket 1) and EUBP (extracellular urea binding pocket), represented by red or blue dashed line respectively. In the intracellular side, the 25a occupied CBBP1 (violet) and CUBP (blue). Residues forming polar interactions or hydrogen bonds with 25a are depicted using triangles. Residues only forming hydrophobic or van der Waals interactions are depicted as solid round circles. The 25a are represented by stick-ball and the hUT-A2 is represented by surface. g Sequence alignment of different UTs in the EBBP1 and CBBP1 regions. The nonconserved amino acids are highlighted with blue background. h The diagram of 25a engaging with the urea binding pocket or potential selective binding pocket with the interfaces represented by blue or violet dashed lines, respectively. Key residues interacting with 25a in these two pockets are shown in blue and violet rectangles, respectively. i, j Effects of hUT-A2 mutants F120L, F120V and L202V on the 25a activity toward hUT-A2 using urease assay. Values are mean ± SEM from three independent experiments (n = 3). The fold changes of IC50 are calculated by dividing the mean value of the mutants by the mean value of the wild type.

Notably, in addition to interacting with residues of the EUBP and CUBP, 25a occupies two additional pockets on the extracellular side and intracellular side, which are named the extracellular blocker binding pocket 1 (EBBP1) and the cytoplasmic blocker binding pocket 1 (CBBP1) (Fig. 6e, f). The EBBP consists of residues from helices 3a and 3b–4b, the LECL, and the ECL2b, and the CBBP consists of residues from helices 3a and 3b, the ICL2a, and the LICL (Supplementary Fig. 9e, f). The benzene ring structure of 25a forms π-π stacking interactions with F1353a of the EBBP on the extracellular side or F1203a, and F3003b of CBBP on the intracellular side (Fig. 6c–f). The terminal end of 25a reached L202LECL, A3264b and P336ECL2b at the pocket end of the EBBP on the extracellular side but reached a relatively open space by contacting L363LICL of CBBP on the intracellular side (Fig. 6c–f). Consistent with these observations, the mutations F120L, F120V, and L202V diminished the binding of hUT-A2 with 25a (Fig. 6g–j and Supplementary Fig. 9g, h).

Collectively, these structural and mutational analyses indicated that the urea channel blocker 25a, by binding to both ends of the transmembrane transport channel (EUBP and CUBP), competes with urea to form hydrogen bonds with the conserved QPb-T5b-T5a-QPa motif necessary for urea transport (Fig. 3f), thereby competitively inhibiting the activity of UT.

Potential of selective UT-A inhibitor design by targeting the EBBP and CBBP

Synthetic compounds with selective activities for UT-A blockade could be used as urea diuretics where conventional salt-transporter blocking diuretics are limited. We next analyzed whether the structure of 25a-hUT-A2 provided clues for selective UT-A inhibitor design. Structural comparison suggested that the amino acids of L202LECL and P336ECL2a of the EBBP in hUT-A2 are replaced by V203LECL and A337ECL2a in hUT-B (Fig. 6g, h), decreasing the hydrophobic volume of the side chains. Molecular dynamics simulation suggests that these changes weaken the hydrophobic interaction between 25a and UT-B (Supplementary Fig. 9i). On the cytoplasmic side, F1203a of the CBBP of hUT-A2 is replaced by L1213a in UT-B (Fig. 6g), which disrupts π-π interactions with the benzene ring of 25a and thus may decrease its binding affinity with UTs. Consistently, the mutations L202V and F120L of hUT-A2 significantly decreased the IC50 of 25a (L202V-IC50 = 3.41 ± 0.01 μM; F120L-IC50 = 1.65 ± 0.02 μM) (Fig. 6i, j). These results indicate that the selective residue differences in the EBBP and CBBP of UT, such as the nonconserved F1203a and L202LECL, could be exploited for selective and potent hUT-A2 inhibitor design (Fig. 6h).

Structural basis of the selective inhibition of UT-A by ATB3

The aminothiazolone derivative UTAinh-B3 (ATB3) is a competitive inhibitor of hUT-A2 (IC50 = 6.38 ± 0.54 μM toward UT-A2), showing approximately 6-fold stronger inhibition potency toward UT-B (Fig. 7a and Supplementary Table 4). To understand the mechanism underlying the selective inhibition of hUT-A2 by ATB3, we solved the cryo-EM structure of ATB3-hUT-A2 at an overall resolution of 3.3 Å (Supplementary Fig. 3a–f). EM densities corresponding to ATB3 were unambiguously detected on both the extracellular and intracellular sides (Figs. 2a, 7b–d and Supplementary Fig. 10a, b). On the extracellular side, the phenyl ring of ATB3 is rotated toward the channel axis by approximately 50°, and the thiazole heterocycle is shifted upward by approximately 1.5 Å compared with 25a (Fig. 7e). This difference in position enables the contact of ATB3 with F2823b in EBBP2 (constituted by F1353a, L202 LECL, F2823b, and L2843b), which does not interact with 25a in the 25a-hUT-A2 complex structure (Fig. 7c, e, f and Supplementary Table 6). Specifically, ATB3 forms both polar and hydrophobic interactions with hUT-A2. In the EUBP, the nitrogen atoms and carbonyl group of the thiazole ring of ATB3 form hydrogen bonds and polar interactions with Q231Pb and T3385b (Fig. 7c, f). Whereas the ortho-methoxy group of ATB3 forms hydrophobic interactions with L2843b and P336ECL2b in EBBP1, the benzene ring and the meta-methoxy group form π-π stacking and hydrophobic interactions with F1353a, L202LECL, F2823b, and L2843b in EBBP2 (Fig. 7c, f). On the cytoplasmic side, the thiazole ring is shifted by 1.5 Å away from the Sm region of the channel and forms polar interactions with Q67Pa and T1763a in the CUBP (Fig. 7d and Supplementary Fig. 10c, d). Notably, the thiazole ring of ATB3 forms extensive polar interactions with the “QPb–TPb–T3a–QPa” motif of the UT channel, which is essential for UT transport. We speculated that competing with urea for interactions with the “QPb–TPb–T3a–QPa” motif underlies the inhibition mechanism of the UT inhibitor ATB3 (Fig. 7c, d and Supplementary Fig. 10d, Supplementary Table 6). Importantly, two specific residues interacting with methoxy groups of ATB3, L202LECL and P336ECL2b, are replaced by V203LECL and A337ECL2b in UTB, respectively (Fig. 7g–i). MD simulation and mutational analysis indicated that these amino acids differences in structurally equivalent residues at the L202LECLP336ECL2b motif (“LP” pocket) contribute to the selective inhibition of hUT-A2 by ATB3 compared with UTB (Fig. 7j–l and Supplementary Fig. 9g, h).

Fig. 7: The mechanism of inhibition and selectivity of Compound ATB3 toward hUTA2.
figure 7

a The concentration dependent blockade of urea transport of hUT-A2 by compound ATB3. Data are shown as mean ± SEM of three independent experiments (n = 3). b The extracellular blocker binding pocket (EBBP) and cytoplasmic blocker binding pocket (CBBP) of ATB3 in hUT-A2. c, d The interactions between hUT-A2 and ATB3 in EBBP (c) or CBBP) (d). The H-bonds are shown as red dashed lines. e Structural comparison of 25a and ATB3 in EBBP. f The ATB3 occupied three subpockets in the extracellular side, the EBBP1, EBBP2, and EUBP. Residues forming polar interactions or hydrogen bonds with ATB3 are depicted using triangles. Residues forming hydrophobic or van der Waals interactions are depicted as solid round circles. The residues F135, L202, and L284 are shared by both EBBP1 and EBBP2. g, h. The methoxy groups of ATB3 formed hydrophobic interaction with L202 and P336 in hUT-A2, whereas ATB3 don’t form similar interactions with structural equivalent amino acid V203 and A337 in hUT-B. The black dashed lines represent the shortest distance. i Barcode comparisons of the residues involving in the EBBP of different UTs. The residues engaged interactions with 25a, ATB3 and HQA2 are colored orange, and the special residues only interact with ATB3 or HQA2 are colored red or green, respectively. The amino acid of hUT-A2 are displayed on the top line and bottom, with the residues in “L-P” pocket and “SCG” pocket colored magenta and green, respectively. The letters inside the black circles represent the non-conserved amino acids of hUT-A3 or hUT-B. j The comparison between the best estimate residue energy contributions of residues L202 or P336 for their interaction with ATB3 and their corresponding L202V, P336A mutants. k Effects of hUT-A2 mutants L202V and P336A on the ATB3 activity toward hUT-A2. Values are mean ± SEM from three independent experiments (n = 3). l The diagram of ATB3 engaging with the urea binding pocket or “L-P” pocket with the interfaces represented by blue or violet dashed lines, respectively.

Structural basis of uncompetitive inhibition of UT-A by CF11

In contrast to the competitive inhibition mode of 25a and ATB3, UTAinh-F11(CF11) was reported as an uncompetitive inhibitor of UT-A, with an EC50 approximately 10 times better for UT-A1 than UT-B (Supplementary Table 4). The IC50 of CF11 toward hUT-A2 was determined to be 2.78 ± 0.32 μM (Fig. 8a and Supplementary Table 4). Importantly, CF11 was observed only on the intracellular side of hUT-A2, without detectable EM density on the extracellular side (Fig. 8b–d and Supplementary Fig. 10e, f). These observations suggested that urea can still bind to the extracellular side of UT-A2 but cannot be transported into the intracellular side; thus, the interaction is unproductive (bound but not released). We therefore speculated that the specific binding mode of CF11 provides a mechanistic explanation for the uncompetitive inhibition of CF11 (Fig. 8b).

Fig. 8: The structural characterization of Compound UTAinh-F11 binding to hUT-A2.
figure 8

a The concentration dependent blockade of urea transport of hUT-A2 by Compound UTAinh-F11 (CF11). Data are shown as mean ± SEM of three independent experiments (n = 3). b The CF11 bound in the cytoplasmic side of hUT-A2 without occupying the urea binding pocket. c The cryo-EM density of CF11 (red mesh) contoured at 4.0 σ level is located in a cavity surrounded by helices 3a–4a, Pa, ICL2a, and LICL. d The key residues of hUT-A2 in CF11 binding pocket are shown by blue sticks. The CF11 is represented by green stick-ball. e The cutaway view of the binding pocket of CF11. The EUBP and the CUPB are represented by blue and green dashed line, respectively. Residues forming polar interactions or hydrogen bonds with CF11 are depicted using triangles. Residues only forming hydrophobic or van der Waals interactions are depicted as solid round circles. f, g Comparison of different amino acids in the CF11 binding pocket between hUT-A2 (f) and hUT-B (g). The A1153a of hUT-A2 is replaced by L1163a of hUT-B, thus cause a steric hindrance to the chlorine atom of CF11. The F1203a of hUT-A2 is replaced by L in hUT-B, therefore losing π–π stacking (orange dashed lines) with the benzene rings of CF11. h Barcode comparisons of the residues involving in the CBBP of different UTs. The residues participated in interactions with 25a, ATB3, and CF11 are displayed as black circles filled orange, and the special residues only interacting with CF11 are shown as black circles filled green. The amino acid sequences of hUT-A2 are shown on top, with the special residues involving in “A-F UCBP” marked by light blue color. The letters inside the black circles filled with light blue represent the non-conserved amino acids in the “A-F UCBP” of hUT-A3 or hUT-B. i The diagram of binding mode of CF11, with the hUT-A2 interfaces represented by blue or light blue dashed lines, respectively. Key residues interacting with CF11 in “A-F UCBP” are shown in blue and light blue rectangles, respectively.

On the intracellular side, CF11 is located in the cavity surrounded by helices 3a–4a, Pa, ICL2a, and LICL (Fig. 8c). CF11 is a γ-sultambenzosulfonamide-type inhibitor, with two benzene rings connected by a nitrogen-sulfur bond. The methoxy group of CF11 inserts into CUBP but does not contact T176, V68, and F341 and only forms hydrophobic contacts with Q67Pa and F70Pa, leaving an empty space in the UT transport channel (Fig. 8d, e and Supplementary Table 7). Therefore, CF11 cannot compete with urea molecules to form polar interactions with the Q231Pb–T3385b–T1765a–Q67Pa motif of the CUBP, a common feature shared by competitive inhibitors 25a and ATB3. These structural features provided additional insights into the uncompetitive inhibition mode of CF11.

The specific residues encompassing the uncompetitive inhibitor CF11 were named the uncompetitive binding pocket (UCBP) (Fig. 8e). Inside the UCBP, CF11 formed hydrophobic interactions with A1153a, M2993b, L363LICL, and V366LICL. The two benzene rings of CF11 form π–π stacking interactions with F1203a, whereas the nitrogen-sulfur atoms connecting the two benzene rings form hydrogen bonds with the hydroxyl group of Y1233a and the main chain atoms of V1745a–F1755a. In addition, CF11 participates in π-π stacking with F3003b (Fig. 8d, e). According to the sequence alignment of different UTs, we found that two nonconserved amino acids in UCBP, A1153a, and F1203a of hUT-A2, may contribute to the selectivity of F11 (Fig. 8f–h). Notably, A1153a in UT-A2 is replaced by L1163a in UT-B, which may provide steric hindrance to the chlorine atom of CF11, decreasing the binding affinity (Fig. 8f, g). This speculation was supported by structure-function relationship studies: replacing the chlorine atom with a hydrogen atom in CF11 improved the inhibition potency against UT-B20. Moreover, F1203a of hUT-A2 is replaced by L in hUT-A3 and hUT-B, losing π-π stacking with the benzene rings of CF11 (Fig. 8f, g). Therefore, A1153a and F1203a of UCBP are key residues of hUT-A2 that contribute to the selectivity of CF11, and we named the pocket the “A-F UCBP”. In summary, specific UCBP residues of UT-A2, such as A1153a and F1203a, could be utilized for inhibitor design targeting hUT-A2 for both uncompetitive inhibition and selectivity (Fig. 8i).

Mechanism of noncompetitive inhibition of UT-A by targeting an “SCG” pocket

The 8-hydroxyquinoline derivative UTAinh-A2 (HQA2) is a noncompetitive inhibitor of UT-A, with selectivity against UT-B of more than tenfold (IC50 for UT-A1 vs. UT-B is approximately 5 μM vs. 50 μM) (Supplementary Table 4)21. The IC50 values of HQA2 for blocking urea transport mediated by hUT-A2 were 3.66 ± 0.09 μM (Fig. 9a). In the HQA2-hUT-A2 complex structure, only one binding site located on the extracellular side of hUT-A2, located in the cavity surrounded by helices 3a, 3b–4b, and Pb, and the LECL, and ECL2b (Fig. 9b, c). Distinct from all other competitive inhibitors and uncompetitive inhibitors, which bind perpendicularly to the extracellular side of UT, HQA2 binds parallel to hUT-A2. Notably, the benzene ring of HQA2 is located in EBBP1 and EBBP2 (EBBP1-2). In EBBP1-2, the benzene ring of HQA2 forms π–π stacking with F1353a and hydrophobic interactions with L202LECL, L2843b, P335ECL2b, and P336ECL2b, including interactions with the “L-P” selective pocket (Fig. 9d, e and Supplementary Table 8). In particular, the methoxy group in the benzene ring of HQA2 extends into the EUBP, forming a hydrogen bond with the side chain of Q2315b (Fig. 9d, e), without occupying the entire EUBP or the CUBP, thereby affording a potential mechanism of noncompetitive inhibition of urea transport.

Fig. 9: Mechanism of noncompetitive blocking hUT-A2 by HQA2.
figure 9

a The concentration dependent blockade of urea transport of wild type hUT-A2 and S279D, C285W mutants by HQA2. Values are mean ± SEM from three independent experiments (n = 3). b The HQA2 bound in the extracellular side of hUT-A2 without occupying the urea binding pocket. The hUT-A2 are represented in blue cartoon and the HQA2 shows as orange stick-ball. c The cryo-EM density (blue mesh) of HQA2 at the 4.0 σ contour level is located in the cavity surrounded by helices 3a, 3b–4b, and Pb, and the LECL, and ECL2b. d The key residues of the HQA2 binding pocket of hUT-A2 are represented by sticks and the residues involving in the “SCG” pocket are colored green. The H-bond are shown as red dashed line. e The cutaway view of the binding pocket of HQA2 (orange stick-ball). The EUBP, EBBP1-2 and the noncompetitive “SCG” pocket are represented by blue, red and green dashed line respectively. Residues forming polar interactions or hydrogen bonds with HQA2 are depicted using triangles. Residues only forming hydrophobic or van der Waals interactions are depicted as solid round circles. The HQA2 are represented by orange stick-ball and the hUT-A2 are represented by surface. f Sequence alignment of the structurally equivalent residues in the noncompetitive SCG pocket of hUT-A2 compared with other UT members including hUT-A3, rUT-A4 (rat UT-A4), mUT-A5 (mouse UT-A5), hUT-B, bUT-B (bovine UT-B) and zf-UT. Key residues of SCG pocket in hUT-A2 are shown in red font on the top line. Sequences with the same amino acids as the SCG pocket of hUT-A2 are represented in red, while those with non-conserved amino acids are represented in light blue. g The diagram of HQA2 engaging with the extracellular urea binding pocket (EUBP), L-P pocket and the noncompetitive SCG pocket with the interfaces represented by blue, violet and green dashed lines, respectively. Key residues interacting with L-P pocket and SCG pocket are shown in violet and green rectangles, respectively. The H-bond between HQA2 and residues S279 is shown as red dashed line.

Importantly, the hydroxyquinoline moiety is rotated by approximately 90° and occupies a side pocket encompassing 6 residues with small side chains, named the SCG pocket (Supplementary Fig. 10g). In the SCG pocket, the hydroxyl group of the hydroxyquinoline moiety forms a hydrogen bond with the side chain of S2793b and van der Waals interactions with T275ECL1b, C2853b, G3224b, and A3234b (Fig. 9d and Supplementary Fig. 10h, i). Sequence alignment showed that the amino acid sequences in the SCG pockets of different UTs are not conserved, especially for residues S2793b, C2853b, and G3224b (Figs. 7i, 9f). Importantly, mutations of SCG pocket residues to structural equivalent residues in other UT members, such as S279D or C285W, significantly decreased the activity of HQA2 in blocking urea transportation (Fig. 9a and Supplementary Fig. 7k, l). These results suggested that this pocket has potential for designing hUT-A/B selective inhibitors. Moreover, the region where the SCG pocket is located is completely independent of the urea transport channel of hUT-A2 and may therefore serve as an allosteric pocket for ligand binding to regulate UT-mediated urea transportation (Fig. 9e–g).

Discussion

In the present study, we determined 11 cryo-EM structures of four UT members, including hUT-A2, hUT-A3, hUT-B and zf-UT, in resting states (apo structure) and bound with urea, two synthetic competitive inhibitors, one uncompetitive inhibitor and one noncompetitive inhibitor. These structures not only provided direct snapshots for the observation of urea transport through UTs but also revealed the structural mechanisms underlying urea transport and selective inhibitor design targeting UT-A2 in competitive, uncompetitive and noncompetitive modes, offering the potential to create a new class of diuretics. Notably, compared with the apo-hUT-A2 structure, the binding of urea induced inward movements of residues along the urea transport channel in the urea-hUT-A2 complex structure, leading to a shrinkage of the channel radius by approximately 0.3 Å. Further structural analysis, combined with MD simulation, sequence alignment and mutational analysis, indicated that the urea recognition motif (URM), which comprises Q67PaV68PaY1233aT1765a in the CUBP and Q231PbV/I232PbF/Y2873bT3385b in the EUBP, is conserved among most UT members and is responsible for urea recognition and transportation. In particular, rotating urea via H-bond transfer through the Q231Pb–T3385b–T1765a–Q67Pa polar motif along the transport channel may be the key to the driving force for urea transport. We have also conducted MD simulations of the process of urea permeation based on the urea-bound hUT-A2 and zf-UT structures. It is worth to note that the calculation of the free energy changes in urea molecules passing through the transport channel is still challenging and variable, because urea needs to get rid of water to pass Sm region and the role of waters in the urea permeation process is not yet clear22,23,24. Our results showed that significant energy barriers are found in the Sm region compared to the Si and So regions, and the valley values of the free energy in the Sm region are higher than those in the Si and So regions. These features of the energy are consistent with the structural information of the urea-bound UTs and the MD simulation of urea permeation processes described by Ming Han et al.19,22,25 (Supplementary Table 9). Combining the MD simulation results with the information offered by structural models and biochemical experiments, we finally speculated that the urea transport route is as follows (Supplementary Movie): (1) the extracellular free urea molecule is first captured by H-bonding to the side chain of Q231Pb and then enters the So region. The binding of urea within the EUBP is further stabilized by the formation of another hydrogen bond with T3385b. (2) The urea molecule is guided into the Sm region of the channel by a swing of the T3385b side chain. In the Sm region, urea molecules alternately form hydrogen bonds with the side chains of T3385b and T1765a, reorienting the oxygen atom of urea. (3) A swing of the T1765a side chain rotates the urea molecule for transfer to the Si region in the CUBP. (4) With the movement of the Q67Pa side chain in the CUBP, urea molecules leave the Si region and enter the cell, completing transport. In addition, the movement of urea molecules in the channel is restricted by the hydrophobic amino acid pairs on both sides of the channel, so that only one urea molecule at one time is allowed to pass through a given position in the channel, and this mechanism ensures that urea molecules are transported across the membrane in only one direction at a time. Notably, we didn’t include water in our simulation, which needs further exploration. A similar mechanism is proposed for zf-UT according to structural observation, MD simulation and mutational analysis.

Selective inhibitors of UT are a potential new class of salt-sparing diuretics. Notably, structural analysis revealed that the competitive, uncompetitive and noncompetitive inhibitors bind to hUT-A2 via distinct modes and different binding pockets. Two competitive inhibitors, 25a and ATB3, occupy both the EUBP and the CUBP, competing with urea for H-bonding with the “QPb–T5b–T5a–QPa” motif, thus providing a mechanism of competitive inhibition. Moreover, the nonconserved residues L202LECL and P336ECL2b in the EBBP of hUT-A2 (also called the LP pocket) interact with both competitive inhibitors and could be utilized for the design of selective competitive inhibitors of hUT-A2. Distinct from competitive inhibitors, the uncompetitive inhibitor CF11 and noncompetitive inhibitor HQA2 bind to hUT-A2 in two different pockets localized on either the cytoplasmic or extracellular side, named the UCBP and the SCG, respectively. Whereas the binding of CF11 solely at the cytoplasmic side via the UCBP allow urea entry but blocks urea transport, the SCG pocket may be utilized as an allosteric site for inhibitor design. In addition, key residues in the UCBP and SCG pocket were identified for selective inhibitor design targeting hUT-A2, which is half part of hUT-A1 C-terminal. Moreover, our structures reveal that certain UT inhibitors, such as CF11, exclusively bind to the intracellular pocket of the urea transporter. These inhibitors require membrane crossing to exert their inhibitory effect (Supplementary Table 10) on urea transport, suggesting that it is crucial to take into account the transmembrane efficiency for modifying the UTAinh-F type urea channel blockers as intracellular binders. Taken together, our study not only afforded direct observation and a structural understanding of urea transport via UTs but also provided a landscape of the structural basis of hUT-A2 inhibition by different inhibitors, which may facilitate the design of selective hUT-A inhibitors with either competitive, uncompetitive or noncompetitive modes.

Methods

Constructs

The human UT-A1, -A2, -A3, -B and zebrafish UT genes were cloned into pcDNA3.1 and pFastBac1 vector for functional assays and protein expression, respectively. To facilitate expression and purification, the full-length sequence of these UTs were introduced into the pcDNA3.1 or pFastBac1 expression vector with a Flag tag at the N terminus, and a Tobacco Etch cleavage site and mCherry sequence were added to the C-terminus.

Measurement of receptor cell-surface expression by western blot

To accomplish comparative plasma membrane expression levels of wild type and mutants of hUT-A2, hUTA3, hUT-B and zf-UT, the plasmid amount were adjusted and transfected into HEK293 cells, and their expression levels were confirmed by Western blot. HEK293 cells were transiently transfected with pcDNA3.1-hUT-A2, pcDNA3.1-hUT-A3, pcDNA3.1-hUT-B, pcDNA3.1-zf-UT, hUT-A2 mutants or zf-UT mutants, respectively. Forty-eight hours after transfection, the transfected HEK293 cells were collected and then washed in pre-colded HBSS buffer and centrifuged at 600 g at 4 °C for 5 min. And then the cell pellets were homogenized and centrifugated at 600 g at 4 °C for 30 min to remove fractions of nuclei and cell apparatus. The supernatant was further centrifugated at 60,000 g at 4 °C for 30 min to collect the cell membranes. The membranes were then homogenized and solubilized with HBSS buffer containing 1% (w/v) DDM and protease inhibitor for 2 h at 4 °C with end-to-end rotation. After that, the solubilized membrane supernatant was collected by centrifugated at 60,000 g for 30 min to remove the precipitate, and then were subjected to SDS-polyacrylamide gel electrophoresis and Western blot for further analysis. For detection of the hUT-A2, hUT-A3, hUT-B, zf-UT, the anti-FLAG (1:1000, Sigma, F1804) primary antibody and HRP-conjugated goat anti-mouse IgG (1:5000, ThermoFisher, A16066) secondary antibody were used. For detection of the membrane reference, the anti-ATP1A1 (1:1000, Proteintech, 14418-1-AP) primary antibody and the HRP-conjugated goat anti-rabbit IgG (1:5000, Sigma Aldrich, A6154) secondary antibody were used.

Detection of urea transportation by using 14C-labeled urea

HEK293 cells were transfected with different UTs or their mutants by using Polyethyleneimine (PEI) with a volume ratio at 1:3 of plasmids and PEI. After transfection for 48 h, each well was incubated with 300 μl of DMEM supplemented with 10 mmol/L urea and 1 μCi of 14C-urea for 30 min. After incubation, the cells were rinsed three times with cold 1 × PBS for 20 s each time. Subsequently, 500 μl of 10% SDS was added to each well to lyse the cells for 5 min. The resulting cell lysate was then combined with 5 ml of scintillation fluid in a scintillation vial for subsequent measurement using a scintillation counter. In the experiment evaluating the inhibitory function of the inhibitor, 100 μmol/L of 25a was added to DMEM with 10 mmol/L urea and 1 μCi of 14C-urea in or the 1 × PBS buffer for incubation or washing, And the remaining steps remained unchanged.

Detection of urea transportation and the effect of inhibitors by using the urease assay

HEK293 cells were transfected with different UTs or their mutants using Polyethyleneimine (PEI). After transfection for 48 h, the cells were resuspended and divided into aliquots. The aliquots were incubated with 50 μmol/L urea and different concentrations of each inhibitor, and then reach equilibrium state by shaking at 200 rpm in 37 °C incubators. After equilibrium, cells were collected by centrifuged at 200 g and washed with HBSS buffer containing corresponding concentration inhibitor for 1 min. After washing, cells were dilated in water, and broken by 300 W ultrasonication for 3 min to release the reserved urea. To detect the urea amount, we followed the instruction of the BUN detection kit (BC1535, Solar-bio Life Sciences, Beijing,). Firstly, the broken cells were centrifuged at 25,000 g for 15 min, and the supernatant were mixed with reagent I and reagent II and incubated at 37 °C for 10 min. After incubation, they were mixed with reagent III and reagent IV and incubated at 37 °C for 30 min. Finally, the enzyme catalyzed solutions were measured with microplate-reader under 630 nm wavelength. The urea concentrations were calculated by compared to the standard urea solution. And the inhibition effects were represented by dose curve fitted by three-parameter dose-response model using GraphPad software.

Expression and purification of different UT proteins in SF9 cells

Recombinant baculovirus was generated using the Bac-to-Bac Baculovirus Expression System (Invitrogen). Briefly, FuGENE HD transfection reagent (Promega) was used to prepare baculovirus. SF9 insect cells were seeded in ESF921 medium at a density of 2.5 × 106 cells/ml and infected with zf-UT, hUT-A2, hUT-A3 or hUT-B baculovirus. After 48 h incubation at 27 °C, shaking at 110 rpm, cells were collected by centrifugation, flash-frozen in liquid nitrogen and stored at −80 °C. For structural determination, the cells were resuspended in lysis buffer (20 mM HEPES, pH 7.4, 100 mM NaCl, 5 mM CaCl2, 2.5 mg/ml leupeptin and 0.2 mg/ml benzamidine) and grinded into membranes with Dounce. The cell lysate was then solubilized by 0.5% (w/v) lauryl maltose neopentylglycol (LMNG; Anatrace) and 0.1% (w/v) cholesteryl hemisuccinate TRIS salt (CHS; Anatrace) for 2 h at 4 °C. The supernatant was collected by centrifugation at 25,000 g for 30 min, and the solubilized sample solution was incubated with M1 anti-FLAG resin for 2.5 h at 4 °C. The sample solution was immobilized on Flag-M1 resin, loaded on a Flag-M1 column, and washed with 20 column volumes of 20 mM HEPES, pH 7.4, 100 mM NaCl, 5 mM CaCl2, 0.01% (w/v) LMNG, 0.002% (w/v) CHS, 2.5 mg/ml leupeptin and 0.2 mg/ml benzamidine. The protein solution was then eluted with 20 mM HEPES, pH 7.4, 100 mM NaCl, 2.5 mg/ml leupeptin, 0.2 mg/ml benzamidine, 0.0005% (w/v) LMNG, 0.0001% (w/v) CHS, 10 mM EDTA and 0.2 mg/ml FLAG peptide (GL Biochem). The protein solution was collected and concentrated, then loaded onto a Superose 6 Increase 10/300 GL column (Cytiva) with buffer containing 20 mM HEPES, pH 7.4, 100 mM NaCl, 0.00075% (w/v) LMNG, 0.0002% (w/v) CHS. The protein fractions were concentrated with a 100 kDa MWCO Millipore concentrator. In order to prepare the complex of inhibitor and UT, 10 μM to 100 μM of inhibitors 25a, ATB3, CF11, and HQA2 were separately added to the above concentrated sample solution and incubated on ice for at least half an hour.

Glutaraldehyde crosslinking

In order to mildly crosslink the UT trimer, an ‘on-column’ crosslinking method was used26. First, 200 μl, 0.25% glutaraldehyde was injected to a pre-equilibrated Superose 6 Increase 10/300 GL column (in 20 mM HEPES, pH 7.4, 100 mM NaCl, 0.00075% (w/v) LMNG, 0.0002% (w/v) CHS) and run at 0.25 ml/min for 20 min. Subsequently, the column flow was paused, and the injection loop was flushed using buffer followed by injection of purified UT solution. Subsequently, the column was run at 0.25 ml/min and 0.3 ml fractions were collected.

Cryo-grid preparation and EM data collection

For cryo-EM grid preparation, the purified UTs after crosslinking homotrimer protein were concentrated to a concentration of 2 mg/ml and applied as 3 μl aliquots onto glow-discharged holey carbon grids. Grids were transferred to a Titan Krios electron microscope (300 kV) equipped with spherical aberration (Cs) image corrector. Images were acquired with a Gatan K3 Summit or Falcon counting camera at a nominal magnification of ×130,000, with pixel sizes on the object scale ranging from 0.82 Å to 1.055 Å, respectively. The Thermo Scientific EPU equipped with customized scripts enabled the automated low-dose image acquisition and the movie stacks were obtained with a defocus range of −1.0 to −2.0 μm. The accumulated dose was set to 60 electrons per Å2 and a total of 32 frames per micrograph.

Image processing and 3D reconstructions

The overall cryo-EM data processing pipeline for all UTs structures are shown in Supplementary Figs. 24. Initial Cryo-EM movie stacks were summed and subjected to Patch Motion Correction dose-weighting and patch CTF estimation in CryoSPARC27 depending on its image processing software.

For apo-hUT-A2 structures, 8034 movie stacks were imported in cryoSPARC v4.2. Each micrograph was manually inspected to take away bad pictures that were contaminated by crystalline ice or other visible contamination. For purpose of better particle-picking, a conventional neural network-based method Topaz implemented in CryoSPARC28 was used for particle picking. Total 2,530,038 particles were extracted with 288 pixels from the dataset and subjected to 2D classification. A clean particle stack of 408,332 from the 2D classification step was selected and re-extracted with a box size of 288 pixels. This clean particle stack was subjected to ab-initio reconstruction and heterogeneous refinement with C3 symmetry served as 3D Classification. Then 183,080 particle projections of the best class were further applied for homogenous refinement and non-uniform refinement with C3 symmetry, generating the best density map with global resolution of 2.8 Å. The calculation processes for other UTs structures are the same as that for the apo-hUT-A2 structure. The detailed processes are shown in Supplementary Figs. 25.

Model building and structure refinement29,30,31,32

The initial template of all the UT structures were derived from the Desulfovibrio Vulgaris UT structure (PDB: 3K3F) using Phyre online server, respectively. Models were rigidly docked into the cryo-EM density map and saved as new models with the coordinates relative to cryo-EM map using UCSF Chimera. All separated coordinates were merged into one PDB file by manual building and adjustment in COOT. The final model was subjected to global refinement and minimization in real space using PHENIX for cryo-EM maps. The Figures were prepared with Chimera and PyMOL (http://pymol.org/).

Molecular dynamics simulations and binding energy calculation

To explore the binding energy of wild type and mutant ATB3 or 25a in hUT-A2, all-atom molecular dynamics simulations were conducted. The simulation model, derived from the cryo-EM structure of the trimer complex within this study, was employed. The CHARMM36m force field33 was used for wild type and mutant hUT-A2-ATB3 or 25a-hUT-A2, lipids, ions, and TIP3P water molecules, consistent with prior research. System setup involved CHARMM-GUI34 for generating MD input files. The wild type and mutant ATB3-hUT-A2 or 25a-hUT-A2 complex was embedded in a pre-equilibrated 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine membrane and solvated in a hexagonal TIP3P water box (size: ~70 Å × 70 Å × 80 Å) with 0.15 M NaCl added for charge neutralization. Membrane orientation relied on the Orientations of Proteins in Membranes database. Simulations began with initial energy minimization (10,000 steps) via Gromacs 2019.635 using a combination of steepest descent (5000 steps) and conjugated gradient (5000 steps) methods. Subsequent stages included heating the system from 0 to 310 K in the NVT ensemble over 1000 ps and production simulations at 1 atm in the NPT ensemble for over 1000 ps with 10.0 kcal mol−1 Å−2 harmonic restraints. The MD production (1000 ns) utilized a 2 fs time step, employing Gromacs 2019.6. Analysis comprised using the particle mesh Ewald method with a 12 Å cutoff for electrostatic interactions. Hydrogen bond constraints utilized the SHAKE algorithm (2 fs integration time step). Post-simulation analyzes were performed using Gromacs 2019.6 and VMD36. Binding energy calculations employed the g_mmpbsa package and the MM-PBSA method37, encompassing potential energy in vacuum, polar solvation energy, and non-polar solvation energy computations. Parameters included a solvent probe radius of 0.14 nm, solvent dielectric constant of 80, and solute dielectric constant of 2. Python scripts facilitated MM-PBSA calculations (MmPbSaStat.py) and assessment of individual residue contributions interacting with ATB3 (MmPbSaDecomp.py).

Metadynamics simulations

Metadynamics38 simulations were employed to investigate urea crossing pathways within the hUT-A2 and zf-UT channels. Gromacs 2019.6 and plumed 2.7.139 were used for this enhanced sampling technique. Gaussian hills were added at 500-step intervals, biasing the potential energy landscape with an initial height of 10 kJ mol−1 and a width of 1000 kJ mol−1, controlled by a bias factor of 15. Two collective variables (CV1 and CV2) guided the metadynamics simulation of urea crossing the hUT-A2, zf-UT pathway. CV1 represented the distance between urea and Q67 center of mass, crucial for urea’s transit. CV2 measured the distance between specific residues (V232/V68 and T338/T176), these residues affect the channel of urea through hUT-A2, zf-UT.

Reporting summary

Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.